What does apheresis — purchase accounting adjustments mean?

These are accounting adjustments made to the carrying values of assets and liabilities of acquired entities within the Apheresis segment to reflect their fair value at the date of acquisition. These adjustments often impact amortization and depreciation expenses in subsequent periods. Investors track these to normalize earnings and understand the impact of M&A activity on segment profitability.

Haemonetics (HAE) Apheresis — Purchase accounting adjustments

Screener

Other segment segments

MedSurg

$1.71M—

Similar metrics at other companies

STCTitle — Purchase accounting adjustments

-$117K—

ZDCybersecurity & Martech — Purchase accounting adjustments

$0+100%

ZDGaming & Entertainment — Purchase accounting adjustments

-$171K-456%

ZDHealth & Wellness — Purchase accounting adjustments

-$437K—

ZDTechnology & Shopping — Purchase accounting adjustments

$0+100%

CORInternational Healthcare Solutions — Purchase accounting adjustments

$0—

Other financials

Income statement

See full

Revenue$339.4M+5.6%

Gross profit$202.8M+5.5%

Operating income$57.5M+6.7%

Net income$33.0M-3.0%

EPS (diluted)$0.72+2.9%

Balance sheet

See full

Cash & equivalents$223.4M-23.7%

Total debt$1.2B-4.1%

Total equity$837.1M-5.1%

Total assets$2.4B-3.9%

Cash flow

See full

Operating cash flow$52.3M+201%

CapEx$7.9M+111%

Free cash flow$44.4M+226%

Valuation

See full

Market cap$3.8B+4.4%

Enterprise value$4.75B+3.9%

P/E25.3×-10.3×

P/S2.8×+0.1×

Profitability

See full

Gross margin59%+2.1pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin21.5%+7.5pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.4×0.0×

Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed: Aug 6, 2026, 6:09 AM EDT
Fiscal quarter: Q1 FY2027
Calendar quarter: Q2 2026
Accession: 0000313143-26-000120

Line item	Apheresis	Med Surg	Total
Carrying amount as of March 28, 2026	$55,931	$600,437	$656,368
Purchase accounting adjustments	—	1,714	1,714
Currency translation	(22)	(1,176)	(1,198)
Carrying amount as of June 27, 2026	$55,909	$600,975	$656,884

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's apheresis — purchase accounting adjustments?: Haemonetics (HAE) reported apheresis — purchase accounting adjustments of $0 in Q2 2026.
What does apheresis — purchase accounting adjustments mean?: These are accounting adjustments made to the carrying values of assets and liabilities of acquired entities within the Apheresis segment to reflect their fair value at the date of acquisition. These adjustments often impact amortization and depreciation expenses in subsequent periods. Investors track these to normalize earnings and understand the impact of M&A activity on segment profitability.